Literature DB >> 20181884

CpG-B oligodeoxynucleotides inhibit TLR-dependent and -independent induction of type I IFN in dendritic cells.

Yi C Liu1, Reginald C Gray, Gareth A D Hardy, John Kuchtey, Derek W Abbott, Steven N Emancipator, Clifford V Harding.   

Abstract

CpG oligodeoxynucleotides (ODNs) signal through TLR9 to induce type I IFN (IFN-alphabeta) in dendritic cells (DCs). CpG-A ODNs are more efficacious than CpG-B ODNs for induction of IFN-alphabeta. Because IFN-alphabeta may contribute to autoimmunity, it is important to identify mechanisms to inhibit induction of IFN-alphabeta. In our studies, CpG-B ODN inhibited induction of IFN-alphabeta by CpG-A ODN, whereas induction of TNF-alpha and IL-12p40 by CpG-A ODN was not affected. CpG-B inhibition of IFN-alphabeta was observed in FLT3 ligand-induced murine DCs, purified murine myeloid DCs, plasmacytoid DCs, and human PBMCs. CpG-B ODN inhibited induction of IFN-alphabeta by agonists of multiple receptors, including MyD88-dependent TLRs (CpG-A ODN signaling via TLR9, or R837 or Sendai virus signaling via TLR7) and MyD88-independent receptors (polyinosinic:polycytidylic acid signaling via TLR3 or ds break-DNA signaling via a cytosolic pathway). CpG-B ODN did not inhibit the IFN-alphabeta positive feedback loop second-wave IFN-alphabeta, because IFN-alphabeta-induced expression of IFN-alphabeta was unaffected, and CpG-B inhibition of IFN-alphabeta was manifested in IFN-alphabetaR(-/-) DCs, which lack the positive feedback mechanism. Rather, CpG-B ODN inhibited early TLR-induced first wave IFN-alpha4 and IFN-beta. Chromatin immunoprecipitation revealed that association of IFN regulatory factor 1 with the IFN-alpha4 and IFN-beta promoters was induced by CpG-A ODN but not CpG-B ODN. Moreover, CpG-A-induced association of IFN regulatory factor 1 with these promoters was inhibited by CpG-B ODN. Our studies demonstrate a novel mechanism of transcriptional regulation of first-wave IFN-alphabeta that selectively inhibits induction of IFN-alphabeta downstream of multiple receptors and may provide targets for future therapeutic inhibition of IFN-alphabeta expression in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20181884      PMCID: PMC2892962          DOI: 10.4049/jimmunol.0903079

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter.

Authors:  T Agalioti; S Lomvardas; B Parekh; J Yie; T Maniatis; D Thanos
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

2.  Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.

Authors:  A Krug; S Rothenfusser; V Hornung; B Jahrsdörfer; S Blackwell; Z K Ballas; S Endres; A M Krieg; G Hartmann
Journal:  Eur J Immunol       Date:  2001-07       Impact factor: 5.532

Review 3.  CpG motifs in bacterial DNA and their immune effects.

Authors:  Arthur M Krieg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

4.  Linking Toll-like receptors to IFN-alpha/beta expression.

Authors:  Gregory M Barton; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

5.  Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.

Authors:  Gunther Hartmann; Julia Battiany; Hendrik Poeck; Moritz Wagner; Miren Kerkmann; Norbert Lubenow; Simon Rothenfusser; Stefan Endres
Journal:  Eur J Immunol       Date:  2003-06       Impact factor: 5.532

6.  RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway.

Authors:  Yu-Hsin Chiu; John B Macmillan; Zhijian J Chen
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

7.  The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets.

Authors:  Hiroaki Hemmi; Tsuneyasu Kaisho; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

8.  Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.

Authors:  Veit Hornung; Simon Rothenfusser; Stefanie Britsch; Anne Krug; Bernd Jahrsdörfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

9.  Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression.

Authors:  S Landmann; A Mühlethaler-Mottet; L Bernasconi; T Suter; J M Waldburger; K Masternak; J F Arrighi; C Hauser; A Fontana; W Reith
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

10.  Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody.

Authors:  Alain P Vicari; Claudia Chiodoni; Céline Vaure; Smina Aït-Yahia; Christophe Dercamp; Fabien Matsos; Olivier Reynard; Catherine Taverne; Philippe Merle; Mario P Colombo; Anne O'Garra; Giorgio Trinchieri; Christophe Caux
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

View more
  10 in total

1.  Activation of type I interferon-dependent genes characterizes the "core response" induced by CpG DNA.

Authors:  Folkert Steinhagen; Corinna Meyer; Debra Tross; Mayda Gursel; Takahiro Maeda; Sven Klaschik; Dennis M Klinman
Journal:  J Leukoc Biol       Date:  2012-07-02       Impact factor: 4.962

2.  Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing.

Authors:  Daimon P Simmons; Pamela A Wearsch; David H Canaday; Howard J Meyerson; Yi C Liu; Ying Wang; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2012-02-27       Impact factor: 5.422

3.  TLR2 signaling depletes IRAK1 and inhibits induction of type I IFN by TLR7/9.

Authors:  Yi C Liu; Daimon P Simmons; Xiaoxia Li; Derek W Abbott; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2012-01-06       Impact factor: 5.422

4.  The Toll-like receptor 9 signalling pathway regulates MR1-mediated bacterial antigen presentation in B cells.

Authors:  Jianyun Liu; Randy R Brutkiewicz
Journal:  Immunology       Date:  2017-06-29       Impact factor: 7.397

5.  Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells.

Authors:  Maarten Buitendijk; Susan K Eszterhas; Alexandra L Howell
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-05       Impact factor: 2.205

6.  RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge.

Authors:  Megan E Ermler; Ekaterina Yerukhim; Jill Schriewer; Stefan Schattgen; Zachary Traylor; Adam R Wespiser; Daniel R Caffrey; Zhijian J Chen; Charles H King; Michael Gale; Marco Colonna; Katherine A Fitzgerald; R Mark L Buller; Amy G Hise
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

7.  Self-priming determines high type I IFN production by plasmacytoid dendritic cells.

Authors:  Gunther Hartmann; Veit Hornung; Sarah Kim; Vera Kaiser; Esther Beier; Matthias Bechheim; Margit Guenthner-Biller; Andrea Ablasser; Michael Berger; Stefan Endres
Journal:  Eur J Immunol       Date:  2014-01-16       Impact factor: 5.532

8.  PyNTTTTGT and CpG immunostimulatory oligonucleotides: effect on granulocyte/monocyte colony-stimulating factor (GM-CSF) secretion by human CD56+ (NK and NKT) cells.

Authors:  Juan M Rodriguez; José Marchicio; Mariela López; Andrea Ziblat; Fernanda Elias; Juan Fló; Ricardo A López; David Horn; Jorge Zorzopulos; Alejandro D Montaner
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

9.  Binding mode of CpG oligodeoxynucleotides to nanoparticles regulates bifurcated cytokine induction via Toll-like receptor 9.

Authors:  Shanmugavel Chinnathambi; Song Chen; Singaravelu Ganesan; Nobutaka Hanagata
Journal:  Sci Rep       Date:  2012-07-26       Impact factor: 4.379

10.  The Dox-pDC - A murine conditionally immortalized plasmacytoid dendritic cell line with native immune profile.

Authors:  Sebastian Thieme; Alexander Holzbaur; Ralf Wiedemuth; Aline Binner; Katrin Navratiel; Konstantinos Anastassiadis; Sebastian Brenner; Cornelia Richter
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.